{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T09:53:06Z","timestamp":1793267586427,"version":"4.5.0"},"reference-count":71,"publisher":"International Society of Global Health","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Glob Health"],"DOI":"10.7189\/jogh.16.04148","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:16:22Z","timestamp":1780035382000},"source":"Crossref","is-referenced-by-count":1,"title":["Resilience to HPV vaccine safety scares in seven countries"],"prefix":"10.7189","volume":"16","author":[{"given":"Mallory K","family":"Ellingson","sequence":"first","affiliation":[{"name":"Gillings School of Global Public Health, University of North Carolina, Department of Health Behavior, Chapel Hill, North Carolina, USA"},{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milkie","family":"Vu","sequence":"additional","affiliation":[{"name":"Feinberg School of Medicine, and Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Department of Preventive Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dur-E-Nayab","family":"Waheed","sequence":"additional","affiliation":[{"name":"University of Antwerp, Centre for the Evaluation of Vaccination, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Saxena","sequence":"additional","affiliation":[{"name":"American Cancer Society, New Dehli, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Pio","family":"de la Hoz","sequence":"additional","affiliation":[{"name":"Universidad Nacional de Colombia, Bogota, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Pasternak","sequence":"additional","affiliation":[{"name":"Columbia University, Center of Science and Society, New York City, New York, USA"},{"name":"Instituto Questao de Ciencia, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Morrissey","sequence":"additional","affiliation":[{"name":"HSE National Immunisation Office, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Hanley","sequence":"additional","affiliation":[{"name":"University of Aberdeen, Institute of Applied Health Sciences, Aberdeen, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Fiscus","sequence":"additional","affiliation":[{"name":"Association of Immunization Managers, Rockville, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsetsegsaikhan","family":"Batmunkh","sequence":"additional","affiliation":[{"name":"National Cancer Council of Mongolia, Ulaanbataar, Mongolia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo","family":"Almeida","sequence":"additional","affiliation":[{"name":"Instituto Questao de Ciencia, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel T","family":"Brewer","sequence":"additional","affiliation":[{"name":"Gillings School of Global Public Health, University of North Carolina, Department of Health Behavior, Chapel Hill, North Carolina, USA"},{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4223","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"key-10.7189\/jogh.16.04148-202605281747-R1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/1529100618760521","article-title":"Increasing Vaccination: Putting Psychological Science Into Action.","volume":"18","author":"Brewer","year":"2017","journal-title":"Psychol Sci Public Interest"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R2","doi-asserted-by":"publisher","first-page":"e072794","DOI":"10.1136\/bmjopen-2023-072794","article-title":"Identifying characteristics that enable resilient immunisation programmes: a scoping review.","volume":"14","author":"Baxter","year":"2024","journal-title":"BMJ Open"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R3","doi-asserted-by":"publisher","first-page":"6710","DOI":"10.1016\/j.vaccine.2023.09.027","article-title":"How to increase and maintain high immunization coverage: Vaccination Demand Resilience (VDR) framework.","volume":"41","author":"Ozawa","year":"2023","journal-title":"Vaccine."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R4","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1016\/j.vaccine.2017.06.015","article-title":"Vaccination resilience: Building and sustaining confidence in and demand for vaccination.","volume":"35","author":"Dub\u00e9","year":"2017","journal-title":"Vaccine"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R5","unstructured":"World Health Organization. Cervical Cancer Elimination Initiative. Available: https:\/\/www.who.int\/initiatives\/cervical-cancer-elimination-initiative. Accessed: 28 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.adaj.2019.10.010","article-title":"Summary of the evidence on the safety, efficacy, and effectiveness of human papillomavirus vaccines: Umbrella review of systematic reviews.","volume":"151","author":"Villa","year":"2020","journal-title":"J Am Dent Assoc"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R7","doi-asserted-by":"publisher","first-page":"2239085","DOI":"10.1080\/21645515.2023.2239085","article-title":"Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review.","volume":"19","author":"Ellingson","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R8","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV Vaccination and the Risk of Invasive Cervical Cancer.","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0140-6736(25)00008-X","article-title":"Nepal set to launch historic HPV vaccination programme.","volume":"405","author":"Neupane","year":"2025","journal-title":"Lancet"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R10","unstructured":"World Health Organization. Nepal vaccinates over 1.46 million girls with the HPV vaccine. 18 June 2025. Available: https:\/\/www.who.int\/nepal\/news\/detail\/18-06-2025-nepal-vaccinates-over-1.46-million-girls-with-the-hpv-vaccine. Accessed: 28 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R11","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.socscimed.2009.11.027","article-title":"Newsprint media representations of the introduction of the HPV vaccination programme for cervical cancer prevention in the UK (2005\u20132008).","volume":"70","author":"Hilton","year":"2010","journal-title":"Soc Sci Med"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R12","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(10)60881-1","article-title":"The India HPV-vaccine suspension.","volume":"376","author":"Larson","year":"2010","journal-title":"Lancet"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12919-020-00192-2","article-title":"Prevention and control of HPV infection and HPV-related cancers in Colombia- a meeting report.","volume":"14","author":"Vorsters","year":"2020","journal-title":"BMC Proc"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R14","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.vaccine.2019.12.019","article-title":"Resilience of HPV vaccine uptake in Denmark: Decline and recovery.","volume":"38","author":"Hansen","year":"2020","journal-title":"Vaccine"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R15","doi-asserted-by":"publisher","first-page":"15945","DOI":"10.1038\/s41598-020-73106-z","article-title":"Potential for cervical cancer incidence and death resulting from Japan\u2019s current policy of prolonged suspension of its governmental recommendation of the HPV vaccine.","volume":"10","author":"Yagi","year":"2020","journal-title":"Sci Rep"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R16","unstructured":"World Health Organization. HPV Dashboard. Available: https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/diseases\/human-papillomavirus-vaccines-(HPV)\/hpv-clearing-house\/hpv-dashboard. Accessed: 28 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R17","unstructured":"International Agency for Research on Cancer, World Health Organization. Cancer Today. Available: https:\/\/gco.iarc.who.int\/today\/. Accessed: 28 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R18","unstructured":"Age of Consent Laws By Country. AgeOfConsent.net. Available: https:\/\/www.ageofconsent.net\/world. Accessed: 28 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R19","unstructured":"World Bank. World Bank Open Data. Available: https:\/\/data.worldbank.org. Accessed: 28 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R20","doi-asserted-by":"publisher","first-page":"e453","DOI":"10.1016\/S2214-109X(16)30099-7","article-title":"Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis.","volume":"4","author":"Bruni","year":"2016","journal-title":"Lancet Glob Health"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/07350015.2019.1623045","article-title":"A Dynamic Model of Vaccine Compliance: How Fake News Undermined the Danish HPV Vaccine Program.","volume":"39","author":"Hansen","year":"2021","journal-title":"J Bus Econ Stat"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R22","doi-asserted-by":"publisher","first-page":"4432","DOI":"10.1016\/j.vaccine.2020.04.055","article-title":"The contagious nature of a vaccine scare: How the introduction of HPV vaccination lifted and eroded MMR vaccination in Denmark.","volume":"38","author":"G\u00f8rtz","year":"2020","journal-title":"Vaccine"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R23","unstructured":"International Agency for Research on Cancer. Age-Standardized Rate (World) per 100 000, Incidence, Females, in 2022 \u2013 Cervix uteri. Available: https:\/\/www.pib.gov.in\/PressReleasePage.aspx?PRID=2233906&reg=3&lang=2. Accessed: 5 May 2026."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/07350015.2019.1623045","article-title":"A Dynamic Model of Vaccine Compliance: How Fake News Undermined the Danish HPV Vaccine Program.","volume":"39","author":"Hansen","year":"2021","journal-title":"J Bus Econ Stat"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R25","unstructured":"Baandrup L, Valentiner-Branth P, Kjaer SK. HPV vaccination crisis and recovery: the Danish case. HPV World. Available: https:\/\/www.hpvworld.com\/articles\/hpv-vaccination-crisis-and-recovery-the-danish-case\/. Accessed 29 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R26","unstructured":"HPV Prevention and Control Board, University of Antwerp. Prevention and control of HPV and HPV related cancers in Denmark: lessons learnt and the way forward. November 2016. Available: https:\/\/www.uantwerpen.be\/en\/projects\/hpv-prevention-and-control-board\/meetings\/prevention-and-contr\/. Accessed: 28 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R27","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1016\/S0140-6736(18)30854-7","article-title":"Rapid response to HPV vaccination crisis in Ireland.","volume":"391","author":"Corcoran","year":"2018","journal-title":"Lancet"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R28","unstructured":"Health Products Regulatory Authority. EU Review concludes that evidence does not support that HPV vaccines cause CRPS or POTS. In: HPRA drug safety newsletter. Available: https:\/\/assets.hpra.ie\/data\/docs\/default-source\/product-updates\/hpra-safety-notices\/hpv-vaccines-documents\/dsn-articles\/drug-safety-newsletter-edition-71-december-2015.pdf?sfvrsn=a842582f_3. Accessed: 28 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R29","unstructured":"HPV Vaccination Alliance. Main page. Available: https:\/\/hpvalliance.wordpress.com\/. Accessed: 28 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R30","unstructured":"HPV Prevention and Control Board. Prevention and control of HPV and HPV-related cancers in Ireland and the UK: lessons learned and the way forward. 2017. Available: https:\/\/www.hpvboard.org\/wp-content\/uploads\/2024\/08\/HPVPCB-meeting-report-dublin-final-22062018.pdf. Accessed: 28 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R31","unstructured":"Brennan L. Irish HPV vaccine campaigner dies aged 26. BBC. 21 March 2019. Available: https:\/\/www.bbc.com\/news\/world-europe-47658210. Accessed 28 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R32","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1016\/S0140-6736(15)61152-7","article-title":"HPV vaccination crisis in Japan.","volume":"385","author":"Hanley","year":"2015","journal-title":"Lancet"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R33","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.4161\/21645515.2014.969618","article-title":"Tracking the global spread of vaccine sentiments: The global response to Japan\u2019s suspension of its HPV vaccine recommendation.","volume":"10","author":"Larson","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R34","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/cid\/ciw647","article-title":"Trends of Media Coverage on Human Papillomavirus Vaccination in Japanese Newspapers.","volume":"63","author":"Tsuda","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R35","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1111\/jog.12822","article-title":"Survey of Japanese mothers of daughters eligible for human papillomavirus vaccination on attitudes about media reports of adverse events and the suspension of governmental recommendation for vaccination.","volume":"41","author":"Egawa-Takata","year":"2015","journal-title":"J Obstet Gynaecol Res"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R36","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1016\/S2468-2667(20)30010-4","article-title":"Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study.","volume":"5","author":"Simms","year":"2020","journal-title":"Lancet Public Health"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12919-020-00192-2","article-title":"Prevention and control of HPV infection and HPV-related cancers in Colombia- a meeting report.","volume":"14","author":"Vorsters","year":"2020","journal-title":"BMC Proc"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R38","first-page":"178","article-title":"[Social considerations affecting acceptance of HPV vaccination in Colombia. A systematic review].","volume":"71","author":"Palencia-S\u00e1nchez","year":"2020","journal-title":"Rev Colomb Obstet Ginecol"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R39","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/21645515.2018.1511667","article-title":"HPV vaccine confidence and cases of mass psychogenic illness following immunization in Carmen de Bolivar, Colombia.","volume":"15","author":"Simas","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R40","unstructured":"Martinez M, Estevez A, Quijada H, Walteros D, Tolosa N, Paredes A, et al. Brote de evento de etiologia desconocida en el municipio de El Carmen de Bolivar, Bolivar, 2014. 2015. Available: https:\/\/www.ins.gov.co\/buscador-eventos\/Paginas\/iqen.aspx. Accessed: 28 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R41","unstructured":"Castro C, Marin M, Munoz N. HPV vaccination in Colombia: From a nightmare to a bright, promising dawn. HPV World. HPV World. 2025. Available: https:\/\/www.hpvworld.com\/articles\/hpv-vaccination-in-colombia\/. Accessed 29 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R42","unstructured":"Acre Division. Available: https:\/\/sipni.datasus.gov.br\/si-pni-web\/faces\/inicio.jsf. Accessed: 30 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R43","unstructured":"Pasternak Taschner N, Almeida PVG, Ferreira FM. Anuario VacinaBR 2025: relatorio estatistico de vacinacao no Brasil. Sao Paulo, Brazil: Instituo Questao de Ciencia; 2025. Available: https:\/\/iqc.org.br\/wp-content\/uploads\/2025\/06\/anuario-vacina-interativo-2025.pdf. Accessed: 28 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R44","unstructured":"Government of Brazil. Instituto Nacional de C\u00e2ncer \u2013 Estimativa. 12 October 2025. Available: https:\/\/www.gov.br\/inca\/pt-br\/assuntos\/cancer\/numeros\/estimativa\/apresentacao. Accessed: 30 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R45","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1590\/s1678-9946201961043","article-title":"Adverse events following Quadrivalent HPV vaccination reported in Sao Paulo State, Brazil, in the first three years after introducing the vaccine for routine immunization (March 2014 to December 2016).","volume":"61","author":"Mauro","year":"2019","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R46","unstructured":"Relatario medico da avaliacao dos casos de notificacao de reacao adversa grave a vacina contra o HPV no Estado do Acre. Sao Paolo, Brazil: Instituo de Psiquiatria do Hospital das Clinicas Faculdade de Medicina \u2013 Universidade de Sao Paulo; 2019. Available: https:\/\/agencia.ac.gov.br\/usp-conclui-vacinas-contra-o-hpv-nao-causaram-problemas-de-saude-em-jovens-acreanas. Accessed: 28 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R47","doi-asserted-by":"publisher","first-page":"6714","DOI":"10.1016\/j.vaccine.2020.08.044","article-title":"Immunization stress-related responses presenting as psychogenic non-epileptic seizures following HPV vaccination in Rio Branco, Brazil.","volume":"38","author":"Marchetti","year":"2020","journal-title":"Vaccine"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R48","unstructured":"Medo de vacina (contra HPV) tamb\u00e9m pode ser doen\u00e7a: entenda o caso do Acre. Veja Sa\u00fade. 3 March 2023. Available: https:\/\/saude.abril.com.br\/medicina\/vacina-contra-o-hpv-acre\/. Accessed: 30 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R49","unstructured":"Ci\u00eancia Suja podcast. The \u201cExperimental Invisibles\u201d: tracking the roots of the anti-vaxx movement in Brazil. The Skeptic. 10 October 2022. Available: https:\/\/www.skeptic.org.uk\/2022\/10\/the-experimental-invisibles-tracking-the-roots-of-the-anti-vaxx-movement-in-brazil\/. Accessed: 30 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R50","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/S1470-2045(23)00118-3","article-title":"India rolls out HPV vaccination.","volume":"24","author":"Burki","year":"2023","journal-title":"Lancet Oncol"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R51","unstructured":"United Nations Development Programme. Universal Immunization WIN (U-WIN). Available: https:\/\/www.undp.org\/india\/u-win-launch. Accessed: 28 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R52","unstructured":"Chatterjee P. Delhi first state to launch HPV vaccine as public health programme in schools. Indian Express. 1 March 2016. Available: https:\/\/indianexpress.com\/article\/cities\/delhi\/delhi-first-state-to-launch-hpv-vaccine-as-public-health-programme-in-schools\/. Accessed: 28 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R53","unstructured":"World Health Organization. Punjab launches HPV vaccine with WHO support. 12 July 2017. Available: https:\/\/www.who.int\/india\/news-room\/detail\/12-07-2017-punjab-launches-hpv-vaccine-with-who-support. Accessed: 28 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R54","doi-asserted-by":"publisher","first-page":"A17","DOI":"10.1016\/j.vaccine.2021.07.024","article-title":"Human papillomavirus (HPV) vaccine introduction in Sikkim state: Best practices from the first statewide multiple-age cohort HPV vaccine introduction in India-2018-2019.","volume":"40","author":"Ahmed","year":"2022","journal-title":"Vaccine"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R55","unstructured":"Modi N. RSS-affiliate writes to PM Modi not to introduce HPV vaccine - The Economic Times. 5 December 2017. Available: https:\/\/economictimes.indiatimes.com\/news\/politics-and-nation\/rss-affiliate-writes-to-pm-modi-not-to-introduce-hpv-vaccine\/articleshow\/61935338.cms?from=mdr. Accessed: 28 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R56","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/S1470-2045(22)00567-8","article-title":"HPV vaccination in south Asia: new progress, old challenges.","volume":"23","author":"The Lancet Oncology","year":"2022","journal-title":"Lancet Oncol"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R57","unstructured":"Cervical Cancer Vaccination Campaign Launched. Available: https:\/\/www.pib.gov.in\/PressReleasePage.aspx?PRID=2233906&reg=3&lang=2. Accessed: 5 March 2026."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R58","doi-asserted-by":"publisher","first-page":"100175","DOI":"10.1016\/j.pvr.2019.100175","article-title":"HPV genoprevalence and HPV knowledge in young women in Mongolia, five years following a pilot 4vHPV vaccination campaign.","volume":"8","author":"Batmunkh","year":"2019","journal-title":"Papillomavirus Res"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R59","first-page":"1846263","article-title":"Formative research to inform information, education and communication materials ahead of HPV vaccine re-introduction in Mongolia.","volume":"7","author":"Dalmau","year":"2020","journal-title":"Cogent Med"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R60","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1016\/j.vaccine.2018.06.066","article-title":"HPV immunization programs: Ensuring their sustainability and resilience.","volume":"36","author":"Vorsters","year":"2018","journal-title":"Vaccine."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R61","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/j.vaccine.2023.08.057","article-title":"Pandemic-related resilience in HPV vaccination programmes \u2013 Perspectives from selected countries in Africa on what it will take to vaccinate 90% of girls by 2030.","volume":"42","author":"Kouassi","year":"2024","journal-title":"Vaccine"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R62","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1177\/10755470221129608","article-title":"Benefits and Pitfalls of Debunking Interventions to Counter mRNA Vaccination Misinformation During the COVID-19 Pandemic.","volume":"44","author":"Schmid","year":"2022","journal-title":"Sci Commun"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R63","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1080\/10463283.2021.1876983","article-title":"Countering Misinformation and Fake News Through Inoculation and Prebunking.","volume":"32","author":"Lewandowsky","year":"2021","journal-title":"Eur Rev Soc Psychol"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R64","unstructured":"World Health Organization. WHO Strategic Communication Framework for effective communications. Geneva, Switzerland: World Health Organization; 2017. Available: https:\/\/www.who.int\/docs\/default-source\/documents\/communicating-for-health\/communication-framework.pdf. Accessed: 28 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R65","doi-asserted-by":"publisher","first-page":"e20181872","DOI":"10.1542\/peds.2018-1872","article-title":"Questions and Concerns About HPV Vaccine: A Communication Experiment.","volume":"143","author":"Shah","year":"2019","journal-title":"Pediatrics"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R66","doi-asserted-by":"publisher","first-page":"e20161764","DOI":"10.1542\/peds.2016-1764","article-title":"Announcements Versus Conversations to Improve HPV Vaccination Coverage: A Randomized Trial.","volume":"139","author":"Brewer","year":"2017","journal-title":"Pediatrics"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R67","doi-asserted-by":"publisher","first-page":"e180016","DOI":"10.1001\/jamapediatrics.2018.0016","article-title":"Effect of a Health Care Professional Communication Training Intervention on Adolescent Human Papillomavirus Vaccination.","volume":"172","author":"Dempsey","year":"2018","journal-title":"JAMA Pediatr"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R68","unstructured":"World Health Organization HPV communication. Available: https:\/\/www.who.int\/teams\/regulation-prequalification\/regulation-and-safety\/pharmacovigilance\/guidance\/operations\/communication. Accessed: 28 July 2025."},{"key":"key-10.7189\/jogh.16.04148-202605281747-R69","doi-asserted-by":"publisher","first-page":"e000381","DOI":"10.1136\/bmjph-2023-000381","article-title":"Understanding the factors that shape vaccination ecosystem resilience: a qualitative assessment of international expert experiences and perspectives.","volume":"2","author":"May","year":"2024","journal-title":"BMJ Public Health"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R70","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1186\/s12913-016-1867-7","article-title":"Exploring pathways for building trust in vaccination and strengthening health system resilience.","volume":"16","author":"Ozawa","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"key-10.7189\/jogh.16.04148-202605281747-R71","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1016\/j.vaccine.2018.06.066","article-title":"HPV immunization programs: Ensuring their sustainability and resilience.","volume":"36","author":"Vorsters","year":"2018","journal-title":"Vaccine"}],"container-title":["Journal of Global Health"],"original-title":[],"link":[{"URL":"https:\/\/jogh.org\/2026\/jogh-16-04148","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:16:27Z","timestamp":1780035387000},"score":1,"resource":{"primary":{"URL":"https:\/\/jogh.org\/2026\/jogh-16-04148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":71,"URL":"https:\/\/doi.org\/10.7189\/jogh.16.04148","relation":{},"ISSN":["2047-2978","2047-2986"],"issn-type":[{"value":"2047-2978","type":"print"},{"value":"2047-2986","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"article-number":"04148"}}